Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 08 01:52PM ET
1.34
Dollar change
+0.21
Percentage change
18.58
%
IndexRUT P/E- EPS (ttm)-1.85 Insider Own13.43% Shs Outstand47.26M Perf Week-30.21%
Market Cap63.96M Forward P/E- EPS next Y-1.07 Insider Trans0.93% Shs Float41.32M Perf Month-63.19%
Income-85.28M PEG- EPS next Q-0.42 Inst Own71.98% Short Float13.28% Perf Quarter-63.78%
Sales4.12M P/S15.52 EPS this Y23.31% Inst Trans20.50% Short Ratio10.97 Perf Half Y-85.11%
Book/sh2.32 P/B0.58 EPS next Y31.91% ROA-60.08% Short Interest5.49M Perf Year-10.67%
Cash/sh2.21 P/C0.61 EPS next 5Y- ROE-68.48% 52W Range1.07 - 11.76 Perf YTD-81.21%
Dividend Est.- P/FCF- EPS past 5Y-63.20% ROI-75.08% 52W High-88.61% Beta1.88
Dividend TTM- Quick Ratio7.62 Sales past 5Y40.60% Gross Margin4.53% 52W Low25.23% ATR (14)0.34
Dividend Ex-Date- Current Ratio7.62 EPS Y/Y TTM14.82% Oper. Margin-2195.80% RSI (14)23.89 Volatility33.63% 12.29%
Employees75 Debt/Eq0.03 Sales Y/Y TTM380.09% Profit Margin-2067.99% Recom2.20 Target Price2.00
Option/ShortYes / Yes LT Debt/Eq0.03 EPS Q/Q15.58% Payout- Rel Volume4.05 Prev Close1.13
Sales Surprise222.57% EPS Surprise-1.38% Sales Q/Q704.50% EarningsAug 01 AMC Avg Volume499.96K Price1.34
SMA20-55.30% SMA50-58.87% SMA200-80.27% Trades Volume1,392,117 Change18.58%
Date Action Analyst Rating Change Price Target Change
Oct-02-24Downgrade Needham Buy → Hold
Oct-02-24Downgrade Citigroup Buy → Neutral $8 → $2
Oct-01-24Downgrade H.C. Wainwright Buy → Neutral
Jun-17-24Downgrade BTIG Research Buy → Neutral
Aug-31-22Initiated BTIG Research Buy $12
Jun-01-22Initiated Citigroup Buy $13
May-02-22Initiated H.C. Wainwright Buy $28
Apr-14-21Initiated Berenberg Buy $47
Jan-11-21Initiated Evercore ISI Outperform
Nov-03-20Initiated Needham Buy $34
Today 09:35AM
Oct-02-24 11:32AM
06:57AM
Oct-01-24 12:26PM
06:30AM
06:20PM Loading…
Aug-01-24 06:20PM
04:05PM
Jul-30-24 05:00PM
Jul-01-24 06:00AM
Jun-18-24 06:25PM
10:48AM
Jun-14-24 01:28PM
06:00AM
Jun-10-24 07:30AM
Jun-06-24 07:30AM
09:35AM Loading…
May-21-24 09:35AM
May-14-24 04:15PM
May-07-24 12:00PM
09:55AM
May-04-24 05:31AM
May-02-24 09:58PM
08:25AM
07:05AM
Apr-09-24 04:05PM
Apr-01-24 07:00AM
Mar-04-24 07:00AM
Feb-29-24 04:05PM
Feb-26-24 07:00AM
Feb-14-24 05:06AM
Feb-13-24 06:00AM
07:00AM Loading…
Jan-08-24 07:00AM
Jan-04-24 04:05PM
Dec-21-23 08:00AM
Dec-13-23 10:45AM
06:00AM
Dec-05-23 04:15PM
Nov-14-23 09:00AM
Nov-13-23 08:52AM
Nov-09-23 11:54PM
08:29AM
06:00AM
Nov-06-23 09:28AM
Nov-02-23 09:01AM
Oct-24-23 12:30PM
Aug-10-23 05:15PM
04:00PM
Jul-06-23 10:14AM
May-25-23 05:15PM
May-09-23 05:15PM
04:00PM
Apr-03-23 07:00AM
Mar-21-23 11:50AM
Mar-16-23 08:31AM
Mar-01-23 07:00AM
Feb-27-23 10:46PM
Feb-23-23 04:30PM
Feb-16-23 07:00AM
Feb-09-23 06:01AM
Jan-27-23 08:34AM
Jan-09-23 07:00AM
Dec-13-22 06:51AM
Dec-01-22 09:55AM
Nov-11-22 05:51AM
Nov-08-22 04:30PM
Nov-07-22 08:00AM
Nov-04-22 11:55AM
Nov-03-22 08:30AM
Nov-01-22 04:30PM
Oct-12-22 10:04AM
Oct-05-22 04:30PM
Sep-01-22 04:15PM
Aug-20-22 08:41AM
Aug-11-22 07:00AM
Jul-06-22 07:20AM
May-28-22 08:05AM
May-13-22 08:50AM
May-12-22 07:00AM
May-06-22 09:00AM
May-05-22 09:14AM
Apr-08-22 04:55PM
Apr-05-22 05:00PM
Mar-21-22 12:00PM
Mar-15-22 07:00AM
Mar-09-22 08:21AM
Mar-02-22 08:39AM
Feb-09-22 05:00PM
Feb-02-22 01:38PM
Jan-27-22 09:21AM
Jan-05-22 08:30AM
Dec-13-21 01:57PM
Dec-03-21 07:59PM
Dec-02-21 03:40PM
07:17AM
Dec-01-21 10:45PM
Nov-29-21 10:30AM
Nov-28-21 07:58PM
Nov-26-21 12:39PM
Nov-25-21 11:23PM
05:00PM
Nov-23-21 05:44PM
Shattuck Labs, Inc. engages in the research and development of dual-sided fusion proteins used for medical treatment of cancer and autoimmune disease. It primarily focuses on Agonist Redirected Checkpoint (ARC) and Gamma Delta T Cell Engagers (GADLEN) platforms. It develops a novel class of biologic medicines, capable of multifunctional activity, with potential applications in oncology and autoimmune diseases. The company was founded by Josiah C. Hornblower and Taylor Schreiber in 2016 and is headquartered in Austin, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schreiber TaylorChief Executive OfficerOct 07 '24Buy1.2136,50044,22071,002Oct 08 06:05 AM
Brous TylerDirectorJun 27 '24Buy3.895,41621,068235,088Jul 01 06:30 AM
Brous TylerDirectorJun 28 '24Buy3.903,00011,700238,088Jul 01 06:30 AM
Schreiber TaylorChief Executive OfficerJun 26 '24Buy3.4714,40050,01134,502Jun 26 04:15 PM
Schreiber TaylorChief Executive OfficerJun 04 '24Option Exercise3.573,05010,88820,102Jun 05 06:05 AM
Stout StephenSee RemarksMar 06 '24Option Exercise3.5411,10939,38085,791Mar 08 05:40 PM
Stout StephenSee RemarksMar 06 '24Sale10.5316,004168,52274,437Mar 08 05:40 PM
Neill Andrew RChief Financial OfficerJan 10 '24Sale10.0025,000250,000173,446Jan 16 04:35 PM